NCT07431125

Brief Summary

Unilateral conductive hearing loss (UCHL) in the presence of an intact tympanic membrane represents a diagnostic challenge in otologic practice. In the absence of middle ear effusion or tympanic membrane pathology, stapes fixation secondary to otosclerosis is often considered the most probable diagnosis. However, although otosclerosis is traditionally regarded as a bilateral disease, clinical presentation may be unilateral due to asymmetric disease progression or subclinical contralateral involvement. Other etiologies, including congenital ossicular anomalies, ossicular discontinuity, tympanosclerosis without tympanic membrane involvement, or oval window abnormalities, may mimic otosclerosis both clinically and audiologically. Consequently, exploratory tympanotomy remains the gold standard for definitive diagnosis, allowing direct assessment of ossicular chain mobility and confirmation of stapes fixation. Correlating preoperative clinical suspicion with intraoperative findings is therefore essential to better define the true causes of unilateral conductive hearing loss with an intact tympanic membrane.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2026

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 19, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 24, 2026

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2026

Completed
Last Updated

July 24, 2026

Status Verified

January 1, 2026

Enrollment Period

7 months

First QC Date

February 19, 2026

Last Update Submit

July 23, 2026

Conditions

Keywords

OtoscelrosisExploration Tympanotomystapedectomytympanic membraneconductive hearing loss

Outcome Measures

Primary Outcomes (1)

  • Improvement of the Airborne ( conductive ) gap

    Difference between preoperative and postoperative Average Airbone gap in dicebel

    up to three months Surgery

Study Arms (1)

Patients presented with unilatral conductive hearing loss with intact tympanic memebrane

OTHER

Patients who presented with unilateral conductive hearing loss with intact tympanic membrane will undergo exploration tympanoplasty to diagnose underlying causes and correct them surgically if possible

Procedure: Exporlation Tympanotomy

Interventions

exploration tympanotomy of the middle ear and ossicles to diagnose or detect actual causes of conductive hearing loss and correct it according to the cause

Patients presented with unilatral conductive hearing loss with intact tympanic memebrane

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • unilateral conductive hearing loss or mixed HL with intact Tympanic Membrane

You may not qualify if:

  • Sensorineural hearing loss
  • Chronic otitis media
  • TM perforation
  • Previous ear surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Alazhar university Hopital in Assiut

Asyut, Asyut Governorate, 17511, Egypt

RECRUITING

MeSH Terms

Conditions

Hearing Loss, Conductive

Condition Hierarchy (Ancestors)

Hearing LossHearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

tarek Mansour, head of research committe

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident doctor of otorhinolarngolgoy

Study Record Dates

First Submitted

February 19, 2026

First Posted

February 24, 2026

Study Start

January 1, 2026

Primary Completion

August 1, 2026

Study Completion

August 1, 2026

Last Updated

July 24, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared due to institutional ethical restrictions and the retrospective nature of the study. The dataset contains potentially identifiable clinical and surgical information. De-identified aggregated data may be made available upon reasonable request to the corresponding author, subject to institutional review and approval.

Locations